---
schema_version: "secwatch.filing_event.v1"
accession: "0001513162-23-000023"
form_type: "8-K"
ticker: "BMRA"
cik: "0000073290"
company_name: "BIOMERICA INC"
filed_at: "2023-03-02T23:59:59+00:00"
generated_at: "2026-06-18T16:32:43.956927+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Biomerica appoints Gary Lu as CFO effective March 1, 2023

## Summary
- Gary Lu, 42, previously Controller/VP Finance at Happy Money (Sep 2019-Feb 2023).
- Lu receives $260,000 base salary and option for 75,000 shares vesting 25% annually over 4 years.
- Steve Sloan steps down as interim CFO but remains advisor through Q3 FY2023 10-Q filing.
- Lu is a CPA with a BA in Economics/Accounting from UCLA; began career at Ernst & Young.

## SEC filing metadata
- accession: 0001513162-23-000023
- form_type: 8-K
- ticker: BMRA
- cik: 0000073290
- company_name: BIOMERICA INC
- filed_at: 2023-03-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/0001513162-23-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/bmra-20230301.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001513162-23-000023
- JSON: https://secwatch.observer/filing/0001513162-23-000023.json
- Plain text: https://secwatch.observer/filing/0001513162-23-000023.txt

## Key facts
- Executive change
  Gary Lu was appointed as Chief Financial Officer at BIOMERICA INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective March 1, 2023, the Board of Directors of Biomerica, Inc. (the “Company”) appointed Gary Lu as its Chief Financial Officer, principal financial officer and principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/0001513162-23-000023-index.htm
- Executive change
  Steve Sloan departed as interim Chief Financial Officer at BIOMERICA INC.
  - Action: stepped down
  - Role: interim Chief Financial Officer
  source text: In connection with Mr. Lu’s appointment as Chief Financial Officer, Steve Sloan, the Company’s former Chief Financial Officer and current interim Chief Financial Officer, stepped down as interim Chief Financial Officer, effective as of March 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/0001513162-23-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.